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Case report 
A 32-year-old African-American male with no past his-
tory of  head or neck trauma presented with a one-year 
history of  paresthesias in both arms radiating from his 
neck, with occasional radiation to his upper trunk. The 
symptoms were more pronounced in his left 4th and 5th 
digits. On exam, the patient had a mild decrease in sensa-
tion in his left 4th and 5th digits, which did not split the 
ring finger. His symptoms were reproducible with head 
flexion. Recent plain films of  his cervical spine had not 
shown osseous abnormalities or abnormality of  his 
curvature. 
A cervical MRI showed a 1cm enhancing lesion at the 
C5-C6 level on the postcontrast T1-weighted scan, with 
associated cord edema and cord expansion (Fig. 1). The 
lesion was isointense to slightly hypointense to the cord on 
the precontrast T1-weighted images. The cord edema ex-
tended approximately 5.5cm from C4 to C7. On the T2-
weighted images, the lesion had central low-signal intensity 
with peripheral hyperintensity (Fig. 2A). The T2 scans fur-
ther revealed a proximal hyperintense syrinx, likely postob-
structive, extending 1.8cm from C4-C5 (Fig. 2B). The pres-
ence of  the syrinx increased concern for a space-occupying 
lesion such as an ependymoma or astrocytoma. Based on 
these results, brain, thoracic, and lumbar spine images were 
obtained. The lumbar imaging was unremarkable, and the 
brain MRI showed nonspecific changes. The thoracic im-
age confirmed the presence of  another syrinx distal to the 
lesion extending from T5-T10.
At this point, the patient was started on dexamethasone 
(Decadron), which he discontinued shortly after a few 
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Neurosarcoidosis is a rare diagnosis, and it is also unusual for a patient with sarcoidosis to present solely 
with neurologic disease. However, CNS involvement can be the first manifestation of  disease in 50% of  
patients. Thus, it is an important diagnostic consideration in patients presenting with ambiguous 
nervous-system lesions, particularly in the population most often affected by sarcoidosis: young African-
Americans. We report a case of  a 32-year-old African-American male with spinal sarcoidosis presenting 
as bilateral upper-extremity and upper-trunk parasthesias secondary to an intramedullary spinal lesion. 
Citation: Saadi A, Rajashekara S. Intramedullary spinal neurosarcoidosis. Radiology 
Case Reports. (Online) 2012;7:739.
Copyright: © 2012 The Authors. This is an open-access article distributed under the 
terms of the Creative Commons Attribution-NonCommercial-NoDerivs 2.5 License, 
which permits reproduction and distribution, provided the original work is properly 
cited. Commercial use and derivative works are not permitted.
The authors are medical students at Harvard Medical School, Boston MA. Contact 
Ms. Saadi at altaf_saadi@hms.harvard.edu.
Competing Interests:  The authors have declared that no competing interests exist.
DOI: 10.2484/rcr.v7i4.739
Radiology Case Reports
Volume 7, Issue 4, 2012
Figure 1. 32-year-old male with intramedullary spinal neu-
rosarcoidosis. Postcontrast T1-weighted images revealed a 
1cm enhancing lesion (arrow) at C5-C6 with associated 
cord edema and expansion.
weeks due to intractable hiccups, and was thereafter re-
ferred to a tertiary hospital for neurosurgical evaluation. He 
had presented to this center several months earlier for a 
syncopal episode in the setting of  heavy alcohol use. Dur-
ing that hospital visit, a chest CTA showed bilateral and 
mediastinal lymphadenopathy. The chest CTA results in-
creased suspicion that his spinal lesion could represent neu-
rosarcoidosis. PET CT imaging was therefore obtained to 
further characterize the chest CT abnormalities; it showed 
mildly PET-avid hilar and paratracheal lymphadenopathy. 
A lumbar puncture was not performed due to concern 
about the cord edema, but a serum ACE level was mildly 
elevated at 59 (normal, 7-46). 
The patient was lost to followup for the next ten months 
largely because he had noted symptom improvement. 
When he presented again, the paresthesias had worsened. 
A repeated cervical MRI revealed enlargement of  the en-
hancing mass at the C5-C6 level (Fig. 3A). The patient was 
started on a trial of  60mg prednisone daily. At his followup 
appointment six weeks later, the patient reported that he 
had stopped taking the prednisone after approximately four 
weeks. The reasons for stopping the medication are un-
clear; however, he did note improvement in his left-hand 
paresthesias while taking the prednisone. At this followup, 
he reported increasing neck pain aggravated with head 
turning. Repeated imaging revealed further enlargement of 
the mass and increased cord edema (Fig. 3B).
Given the rate of  growth of  the mass, the concern for 
tumor was quite high, and surgical intervention with biopsy 
and cord decompression was performed. The surgical bi-
opsy demonstrated noncaseating granulomas, confirming 
the diagnosis of  neurosarcoidosis. The patient was man-
aged with prednisone but failed several attempts at wean-
ing, citing exacerbations of  numbness which correlated 
with the increased edema noted on MRI. 
Two years after his operation, the patient continues to 
take immunosuppressive medication, and is currently tak-
ing mycophenolate (CellCept) and adalimumab (Humira). 
His prednisone is being slowly decreased. Cervical MRI 
scans continue to demonstrate some signal abnormality; 
however, the intensity of  the enhancement is markedly 
decreased, as are the caliber of  the cord and surrounding 
edema (Fig. 4A and 4B). Imaging of  the thoracic spine has 
demonstrated resolution of  the syrinx that was seen before 
surgery.
Discussion
Sarcoidosis is a multisystem, noncaseous, granulomatous 
disease of  unknown etiology, typically affecting the lungs 
and mediastinal lymph nodes. It can affect patients of  any 
age, gender, or ethnic background, but the prototypical 
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Figure 2. 32-year-old male with intramedullary spinal neu-
rosarcoidosis. The lesion (arrow) had low signal intensity 
centrally with peripheral hyperintensity on T2-weighted im-
ages (A). A hyperintense syrinx, extending 1.8cm, lay 
proximal to the lesion (arrow) (B).
Figure 3. 32-year-old male with intramedullary spinal neu-
rosarcoidosis. T2-weighted images demonstrated increas-
ing cord expansion and edema (A). Imaging six weeks later 
demonstrated markedly increased cord edema and cord 
expansion extending from C2 to T2 and associated with a 
syrinx in the upper thoracic spinal cord (B).
Figure 4. 32-year-old male with intramedullary spinal neu-
rosarcoidosis. Postoperative MRI scans with laminectomies 
from C4-C7. The postcontrast T1-weighted image showed 
decreased enhancement of the lesion (arrow) at C5-C6 (A), 
and the T2-weighted image showed marked decrease in 
hyperintensity (arrow), both compared to pre-operative 
scans. There was only mild cord enlargement at the level of 
the lesion, and the edema extended only from C4-C7, 
compared to C2-T2 before surgery (B).
patient is an African-American female in the third or fourth 
decade of  life. Clinical involvement of  the nervous system 
occurs in only 5% of  patients with sarcoidosis (1), though 
about 15-25% of  patients with sarcoidosis have CNS in-
volvement on autopsy (2, 3). Approximately 50% of  pa-
tients, like the patient in this case report, present clinically 
without an initial sarcoidosis diagnosis (2), making it im-
perative for physicians to consider neurosarcoidosis in the 
differential. 
The most common sarcoidosis CNS involvement is in the 
brain parenchyma, leptominenges, and cranial nerves, par-
ticularly the facial nerve. These occur in 35%, 40%, and up 
to 50% of  patients, respectively (4, 5). Clinical features of  
neurosarcoidosis are therefore heterogeneous, depending 
on which area of  the CNS is involved and to what extent. 
For example, a patient with a neurosarcoid intraparenchy-
mal mass lesion may present with headache, mental status 
changes, and seizures; while a patient with neurosarcoidosis 
in the hypothalamus may present with disturbances in 
thirst, sleep, appetite, and temperature. Spinal-cord neuro-
sarcoidosis symptoms include myelopathy or radiculopathy, 
as seen with our patient. Importantly, neurosarcoidosis is a 
monophasic illness in two-thirds of  patients, but it can also 
have a relapsing-remitting course or progressive course with 
episodic deteriorations (6). 
Given the variability in clinical symptomatology and time 
course, the diagnosis of  neurosarcoidosis requires MRI 
with contrast to detect abnormalities. Spinal-cord neuro-
sarcoidosis can be intramedullary, extramedullary, or osse-
ous. Intramedullary neurosarcoid spinal-cord lesions, as 
seen in our patient, account for less than 1% of  sarcoidosis 
cases (5). On MR imaging, they manifest typically with fusi-
form cord enlargement, mainly in the cervical and thoracic 
regions (7), low-intensity T1 signal with patchy enhance-
ment, and high-intensity T2 signal. Our patient exhibited 
some of  these features. Extramedullary spinal sarcoidosis 
typically exhibits low-intensity T1 signal with contrast en-
hancement and low-intensity T2 signal. Lastly, osseous in-
volvement is typically seen as well-defined, lytic changes on 
imaging, although skull and vertebral involvement in neu-
rosarcoidosis is very rare (bones of  the hands and feet are 
more commonly involved). 
Despite typical imaging characteristics, these signs can 
mimic other conditions. In the case of  the intramedullary 
spinal lesion seen in our case report, the radiologist must 
differentiate the neurosarcoid spinal lesion from intrame-
dullary tumors such as ependymoma, astrocytoma, or 
glioma; demyelinating disease such as multiple sclerosis or 
ADEM; transverse myelitis; and fungal infection (4, 6); and 
this may not be possible with imaging alone. The treatment 
for each of  these diagnoses varies; operative treatment ef-
fective for malignancy is not effective for steroid- or 
immunosuppressant-responsive spinal-cord sarcoidosis. 
Therefore, the diagnosis of  spinal sarcoidosis is important 
for early, effective treatment and can be aided by accurate 
radiologic assessment, although imaging by itself  is not 
sufficiently specific for diagnosis. 
In addition to imaging of  the spine and head, chest CT 
demonstrating bilateral lymphadenopathy may provide 
additional diagnostic clues, as it did with this patient. Other 
parameters must be considered to aid in diagnosis, includ-
ing serum ACE levels, lumbar puncture, and biopsy. Our 
patient’s serum ACE level was mildly elevated at 59. It is 
important to consider that increased ACE levels are not 
specific for sarcoidosis and can be encountered in disease 
states like meningitis, diabetes, and cirrhosis (5). Lumbar 
puncture was deferred for our patient, given concerns 
about tissue edema seen on imaging, but (if  done) might 
have exhibited characteristic findings such as elevated total 
protein, elevated CSF opening pressure, normal or low 
glucose, mononuclear pleocytosis, and elevated ACE. 
However, Sakushima and colleagues (2011) found that 
spinal-cord sarcoidosis had fewer CSF abnormalities than 
other forms of  neurosarcoidosis (8). Biopsy is ultimately 
definitive in this diagnosis of  exclusion, although attempts 
at extraneural biopsies such as of  the lung, lymph nodes, or 
skin should be made preferentially, given lower morbidity 
and easier access. A high index of  suspicion for the diagno-
sis is also required because early intervention is associated 
with a favorable outcome. Our patient had a good response 
to an initial high-dose steroid therapy (considered first-line), 
but then required methotrexate (second-line) and is now on 
mycophenolate (CellCept) and adalimumab (Humira) as he 
continues to be weaned off  of  prednisone. Other patients 
with progressive spinal neurosarcoidosis may encounter this  
changing medication course. 
Radiologists should keep neurosarcoidosis as a diagnostic 
possibility, even in patients who do not already present with 
a diagnosis of  sarcoidosis, and recognize the imaging mani-
festations. Eighty-seven percent of  neurosarcoidosis cases 
show resolution on imaging, which can parallel clinical 
improvement, as seen with our patient (4), while others 
show progression and recurrence despite treatment, mak-
ing imaging key in both pre- and post-diagnosis evaluation.
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